Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Mobile Mini merger of equals with WillScot
Davis Polk is advising Mobile Mini, Inc. on its all-stock merger of equals with WillScot Corporation to form a combined…
NuVasive $450 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $450 million…
Mobile Mini merger of equals with WillScot
Davis Polk is advising Mobile Mini, Inc. on its all-stock merger of equals with WillScot Corporation to form a combined…
Zhenro Properties Group $200 million high-yield notes offering
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of …
Mobile Mini merger of equals with WillScot
Davis Polk is advising Mobile Mini, Inc. on its all-stock merger of equals with WillScot Corporation to form a combined…
Tellurian $200 million at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Tellurian Inc. of…
Mobile Mini merger of equals with WillScot
Davis Polk is advising Mobile Mini, Inc. on its all-stock merger of equals with WillScot Corporation to form a combined…
NuVasive $450 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $450 million…
Bandwidth $400 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Bandwidth Inc. of an aggregate…
CytomX Therapeutics $75 million at-the-market offering
Davis Polk advised the sales agent in connection with the SEC-registered at-the-market offering by CytomX Therapeutics, Inc…